These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 21389902)
21. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Teramura Y; Iwata H Transplantation; 2009 Sep; 88(5):624-30. PubMed ID: 19741458 [TBL] [Abstract][Full Text] [Related]
22. The role of macrophage migration inhibitory factor in mouse islet transplantation. Toso C; Serre-Beinier V; Emamaullee J; Merani S; Armanet M; Wojtusciszyn A; Bosco D; Calandra T; Roger T; Morel P; Shapiro AM; Berney T Transplantation; 2008 Nov; 86(10):1361-9. PubMed ID: 19034004 [TBL] [Abstract][Full Text] [Related]
23. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746 [TBL] [Abstract][Full Text] [Related]
24. Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. Yasunami Y; Kojo S; Kitamura H; Toyofuku A; Satoh M; Nakano M; Nabeyama K; Nakamura Y; Matsuoka N; Ikeda S; Tanaka M; Ono J; Nagata N; Ohara O; Taniguchi M J Exp Med; 2005 Oct; 202(7):913-8. PubMed ID: 16186183 [TBL] [Abstract][Full Text] [Related]
25. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418 [TBL] [Abstract][Full Text] [Related]
26. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy. Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395 [TBL] [Abstract][Full Text] [Related]
27. Effect of glucose toxicity on intraportal tilapia islet xenotransplantation in nude mice. Al-Jazaeri A; Xu BY; Yang H; Macneil D; Leventhal JR; Wright JR Xenotransplantation; 2005 May; 12(3):189-96. PubMed ID: 15807769 [TBL] [Abstract][Full Text] [Related]
28. Pancreatic islet xenografts at two different transplantation sites (renal subcapsular versus intraportal): comparison of graft survival and morphology. Jaeger C; Wöhrle M; Federlin K; Bretzel RG Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():123-8. PubMed ID: 8839268 [TBL] [Abstract][Full Text] [Related]
29. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Emamaullee JA; Stanton L; Schur C; Shapiro AM Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806 [TBL] [Abstract][Full Text] [Related]
30. Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. Fukuzaki T; Gotoh M; Monden M; Dono K; Ohta Y; Nishihara M; Hasuike Y; Kanai T; Miyasaka M; Mori T Transplant Proc; 1995 Feb; 27(1):354. PubMed ID: 7533407 [No Abstract] [Full Text] [Related]
31. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569 [TBL] [Abstract][Full Text] [Related]
32. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation. Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780 [TBL] [Abstract][Full Text] [Related]
33. Impact of donor immune cells in pancreatic islet transplantation. Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170 [TBL] [Abstract][Full Text] [Related]
34. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761 [TBL] [Abstract][Full Text] [Related]
35. Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation. Desai CS; Khan KM; Ma X; Li H; Wang J; Fan L; Chen G; Smith JP; Cui W Islets; 2017 Nov; 9(6):140-149. PubMed ID: 28902579 [TBL] [Abstract][Full Text] [Related]
36. Factors affecting islet graft embolization in the liver of diabetic mice. Sakata N; Obenaus A; Chan N; Mace J; Chinnock R; Hathout E Islets; 2009; 1(1):26-33. PubMed ID: 21084846 [TBL] [Abstract][Full Text] [Related]
37. Highly Angiogenic, Nonthrombogenic Bone Marrow Mononuclear Cell-Derived Spheroids in Intraportal Islet Transplantation. Oh BJ; Jin SM; Hwang Y; Choi JM; Lee HS; Kim G; Kim G; Park HJ; Kim P; Kim SJ; Kim JH Diabetes; 2018 Mar; 67(3):473-485. PubMed ID: 29298810 [TBL] [Abstract][Full Text] [Related]